Thought Leadership

How CCMS Helps Healthcare Companies Prepare and Translate Medicare Compliance Content

In the United States, the Centers for Medicare & Medicaid Services (abbreviated "CMS" and found online at https://www.cms.gov/) aspires to the following credo:“We pledge to put patients first in all of our programs – Medicaid, Medicare, and the Health Insurance Exchanges. To do...

TransPerfect MT Earns Top Marks at International Machine Translation Competition

As machine translation (MT) technology continues to evolve, it’s increasingly important to look beyond the commercial sphere for the latest in innovation. At TransPerfect, we place special emphasis on the importance of engaging with the research communities specializing in MT...

The Benefits of Translation Memory for Low-Cost Markets and Life Sciences Companies

For life sciences companies expanding into new markets and conducting global clinical trials, accurate translation is critical for effectively communicating with patients. Companies are continually looking for ways to reduce costs and turnaround times of translating extensive...

Top 10 Considerations when Implementing Machine Translation (MT)

Our checklist overviews 10 essential factors to consider when implementing MT for your life sciences content, so you can leverage the benefits of increased quality, reduced costs, and shortened turnaround times this technology offers....

Language Landscape: Latin America

As Latin America (LATAM) is becoming a key market for pharmaceutical companies, the need to connect with the patient population there has increased as well.But is translating your content from English to Spanish LATAM the right approach?As simple as this question may seem, the...

Preparing Compliant eCTD Submissions in Asia

In May 2015, the US FDA published final and binding guidance requiring submission within 24 months of certain Common Technical Documents (CTDs) in an electronic format. This was ratified in 2017 and subsequently revised in February 2020 (Rev. 7). Currently, other notifying bodies...

How to Choose and Implement a CTMS

The clinical development landscape is awash in technologies that automate everything from subject randomization (IVR/IWR) and subject study assessments and outcomes (EDC, ePRO) to trial master file (TMF) solutions.If you are like many emerging small to mid-sized biotech and...

UMotif - Empowering Patients to Drive Engagement and Adherence

Watch this presentation on how empowering patients with cloud solutions increases engagement. ...

TransPerfect’s GlobalLink Helps Top-10 Pharma Meet their EC Deadlines in More than 20 Countries

A top 10 pharma company was facing delays in EC submission deadlines for their global studies....

Lessons Learned in the Rush for a Vaccine and the Effects on Language Translation: Creating and Adapting Technologies

The rush to a vaccine has accelerated an already dynamic research process. This has led to many innovations and an evolution of procedures. The language translation industry has seen enormous stressors and has had to create and modify processes and technologies similarly. The...

The Summary of Safety and Clinical Performance (SSCP) for Healthcare Professionals and Patients

In 2017, the European Parliament and the Council of the European Union (EU) set a regulatory upgrade on medical devices to strengthen governance structure. This regulation update includes increased oversight of notified bodies, new requirements for transparency and traceability,...

ISPOR Europe 2020 Virtual Poster - Usability Testing for eCOAs

In order to ensure a fluid experience for a patient, usability testing is a critical data point to consider. Addressing both a patient’s needs and access to a digital platform is key to data collection. TransPerfect, along with our partners from Parexel, Clinical Ink, and...

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages, leading...

AI Technology Speeds Safety Case Routing

TransPerfect enables a top-10 Pharma company to reduce time to route safety cases....

Medical Annotation: Using Natural Language Processing for Adverse Events

TransPerfect's DataForce Streamlines Adverse Event Detection with NLP. ...

The Paper Chase - Clinical Outcome Assessments in the Digital Age

Patients are, at last, gaining a voice in healthcare. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications that should influence policy and treatment decisions. The U.S. Food & Drug...

Artificial Intelligence in Life Sciences: Latest Developments Presented by Industry Leaders

Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. ...

Swimming in a Data Lake of eCOA Wearables

We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest whitepaper , Mark Wade, Global Practice Leader for TransPerfect Life Sciences examines the considerations of adopting these sensors as an addition...

Wearables for eCOA: Practical Considerations for Improving Patient Data Capture

This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization,...

Part 3: Clinical Trials and COVID-19 Adapting to Rapid Change

The novel COVID-19 virus has forced a lot of rapid change in a very short period of time. Personally and professionally, we are all learning how to adapt. While restrictions on our day-today lives impact where, why, and how we interact, we still can come together as a community...

Part 2: Clinical Trials and COVID-19 Converting to Remote Trial Management – How to Get Started

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to...

Part 1: Clinical Trials and COVID-19: Situation now, its challenges, and the future

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to...

TransPerfect's OneLink Enables BI to Focus on Saving 1000 Lives

The case study highlights how TransPerfect Life Sciences helped Angelini Pharma overcome language barriers in clinical trials, enabling efficient communication and regulatory compliance....